Kansas City

Integrated Kidney Partners XXIII LLC

Primary Contact

Ryan Pardo
Ryan.Pardo@usrenalcare.com


KCE Participants


Practices

Kansas City Kidney Consultants PA

Ahmed Awad Molly Cahill
Ashley Arrowood Munis Mattu
Emily Johnston Rachel Luber
Gretchen Casper Ryan Lustig
Irme Akhtar Suzanne James
Kyrstin Alexander

Kidney Associates of Kansas City PC

Ahmed Al-Absi Andrew Beisser
Karid Nieves-Borrero Nicole Romine
Kelly Alford Pranavkumar Dalal
Mohammed Mohialdeen

Nephrology Associates MD PA

Achal Desai Kristine Herron
Anne Spade Michael Lambert
Archana Goel Najindra Maharjan
Catherine Moss Richard Schumacher
Connie Roe Roberta Mott
Heather Conklin Suganthi Beeki
James Redington Suleiman Daifallah
Justin Teiwes Tessa Weigel
Kamel Hatahet Venu Nair
Deanna Campbell

Wichita Nephrology Group, PA

Amanda Valliant Michael Grant
Edgard Wehbe Mohamad Sandid
Erica Roach Ronnie Moussa
Jany Moussa Shawna Abendroth
Joseph Meouchy Tracy Smith
Levi Short Wissam Saliba

Independent Practitioners

Gautham Mogilishetty

Preferred Providers

Practice Provider Name
Heart Centered Counseling PC
Psycare Inc
Psychiatric and Counseling Associates LLC
Psychological & Behavioral Consultants LLC
Rocky Mountain Kidney Care LLC Chandel Baty
Jourdan Heitschmidt
Stefanie Neill

Joint Ventures

There are no joint ventures between or among the KCE and any of its KCE Participant and Preferred Providers.


Administrative Lead

Name Employer
Alan St. Pierre U.S. Renal Care

Clinical Lead

Name Employer
Dr. Ryan Lustig Kansas City Kidney Consultants

KCE Governing Body Members

Member Title Organization
Alan St. Pierre VP, Market Ops (KCE Manager) KidneyLink
Ryan Lustig M.D. (KCE Medical Director) Kansas City Kidney Consultants
Gautham Mogilishetty M.D. (Transplant Provider) Mogilishetty PLLC
Richard Schumacher M.D. Nephrology Associates
Lori Hartwell Founder (Consumer Advocate) Renal Support Network

Shared Savings and Shared Losses Information

a. Gross Savings/Losses BEFORE CMS withholds
PY2023: $3,551,473
PY2024: $6,676,462

b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation;
PY2023: $823,395
PY2024: $2,483,194

c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2023: 100%
PY2024: 100%

d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2023: N/A
PY2024: N/A


Total Quality Score (TQS)

Performance Year 2023 TQS: 50%
Performance Year 2024 TQS: 86.25%


Total Program Income to Participants

PY2023: $580,987
PY2024: $1,487,126